Life Science Products Market Status (2016-2020) and Forecast Market Analysis, Regional Outlook, Segment Growth Potential, and Competitive Market Share Analysis, 2021-2027
Report Description
The global Life Science Products Market size is estimated at USD 40,100.6 million in 2020, expanding at a CAGR 8.3% from 2021-2027 to reach 46,704.8 Million USD in 2027.
Market Dynamics
Industry participants may concentrate their efforts on extending their business footprint in developing markets. Biotech initiatives could be exported to growing countries including India, which offers a large supply of professional workforce and competent staff at reasonable prices. Increased regulatory attempts to enhance the biosciences industry are likely to provide attractive development prospects for industry participants. For example, the United Kingdom administration announced in March 2020 to spend US$ 24.57 bn annually R&d spending by 2024-25, such as in biological sciences.
Internationally, the COVID-19 outbreak had had a favorable influence on the marketplace for bioscience instruments. The COVID-19 breakout in 2020 had resulted in an enlarged patient population, resulting in an expansion in Research and development. Increased expenditures in drug research are projected to propel the separating techniques market forward. For example, in March 2020, the U.s approved The CARES Act, which includes various clauses linked to the manufacture & testing of items in reaction to the COVID-19 worldwide outbreak. This act allocated USD 3.5 bn to the Bioscience Accelerated Research & Design Agency to finance vaccine manufacture and distribution.
Regional Insights
Asia is predicted to develop at the fastest CAGR throughout the projected timeframe, primarily to increased chronic illness incidence, the expansion of the bioscience sector, expanding use of expanding innovations, and key companies' intensifying attention on expanding their footprint in developing Asian nations.
Segment Insights
The Life Science Products market is divided into three segments: product, application, and end-users. In respect of income, the antibodies category led the industry and is expected to remain to do so during the projected timeline.
Competitive Insights
Major companies in the industry participate in strategic acquisitions and mergers, alliances, and new product releases to stay competitive in the market. For instance, In June 2020, Army Air National Lab geologists collaborated with the Intellect Advanced Research Projects Action as well as College of Michigan-based investigators to develop a pesticide detecting gadget predicated on a chromatographic column that recognizes ARDS/acute breathing illness syndrome caused by SARS-CoV-2.
The report begins with an overview of the Industry Chain structure, describes the industry environment, and then analyses the market size and forecast of the Life Science Products Market by Product, Application, End Users, formulation, application, and region. In addition, this report introduces the market competition situation among the vendors, and company profile, besides, market price analysis, and value chain features are covered in this report.
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products, etc.):
- A.M.S. Biotechnology (Europe) Limited
- Agilent Technologies
- Becton, Dickinson, and Company
- Bio-Rad Laboratories Inc.
- BPS Bioscience Inc.
- Bruker
- Crown Bioscience Inc.
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Genscript Biotech Corporation
- Hitachi, Ltd.
- Illumina, Inc.
- Merck KGaA
- Oxford Instruments plc
- PerkinElmer Inc.
- QIAGEN
- Shimadzu Corporation
- Sigma Aldrich Corp.
- Thermo Fisher Scientific Inc.
- Zeiss International
Product Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):
- Recombinant Proteins
- Immune Checkpoint Regulators
- Chemokines
- Growth Factors
- Cytokines
- Colony Stimulating Factors
- Hormones
- Enzymes & Inhibitors
- Others
- Cell Lines
- Immunotherapy Cell Lines
- Ion Channel Cell Lines
- GPCR Cell Lines
- Cell Signaling Pathway Cell Lines
- Gene Knockout Cell Lines
- Cancer Cell Lines
- Others
- Antibodies
- Immune Checkpoint Antibodies
- Epitope Tag Antibodies
- Isotype Control Antibodies
- Research Use
- In-vivo Grade
- Primary Antibodies
- Research Use
- In-vivo Grade
- Assay Antibodies (includes secondary antibodies)
- Others
-
- Viable Tumor Samples
- Tumor Tissue Microarrays
-
Application Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):
- Drug Discovery & Development
- Tissue Engineering
- Drug Screening
- Toxicity Screening
- Basic Research
- Biopharmaceutical Production
- Forensic Testing
- Therapeutic Application
End-User Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):
- Academic & Research Institutes
- Contract Research Organizations (CROs)
- Forensic Science Laboratories
- Diagnostic Centers
- Others
Region Coverage (Regional Consumption, Demand & Forecast by Countries, etc.):
- North America (U.S., and Canada)
- Europe (Germany, U.K., France, Italy, Spain, etc.)
- Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
- South America (Brazil, Mexico, Argentina, etc.)
- Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa, etc.)
Table Of Content
1. Life Science Products Market Overview
1.1. Product Overview and Scope of Life Science Products Market
1.2. Global Market Growth Prospects and Revenue Estimates
1.3. Global Life Science Products Market Size Growth Rate Analysis by Product 2020 VS 2027
1.3.1. Recombinant Proteins
1.3.1.1. Immune Checkpoint Regulators
1.3.1.2. Chemokines
1.3.1.3. Growth Factors
1.3.1.4. Cytokines
1.3.1.5. Colony Stimulating Factors
1.3.1.6. Hormones
1.3.1.7. Enzymes & Inhibitors
1.3.1.8. Others
1.3.2. Cell Lines
1.3.2.1. Immunotherapy Cell Lines
1.3.2.2. Ion Channel Cell Lines
1.3.2.3. GPCR Cell Lines
1.3.2.4. Cell Signaling Pathway Cell Lines
1.3.2.5. Gene Knockout Cell Lines
1.3.2.6. Cancer Cell Lines
1.3.2.7. Others
1.3.3. Antibodies
1.3.3.1. Immune Checkpoint Antibodies
1.3.3.2. Epitope Tag Antibodies
1.3.3.3. Isotype Control Antibodies
1.3.3.3.1. Research Use
1.3.3.3.2. In-vivo Grade
1.3.3.4. Primary Antibodies
1.3.3.4.1. Research Use
1.3.3.4.2. In-vivo Grade
1.3.4. Assay Antibodies (includes secondary antibodies)
1.3.5. Others
1.3.5.1. Viable Tumor Samples
1.3.5.2. Tumor Tissue Microarrays
1.4. Global Life Science Products Market Consumption Comparison by Application: 2020 VS 2027
1.4.1. Drug Discovery & Development
1.4.2. Tissue Engineering
1.4.3. Drug Screening
1.4.4. Toxicity Screening
1.4.5. Basic Research
1.4.6. Biopharmaceutical Production
1.4.7. Forensic Testing
1.5. Global Life Science Products Market Consumption Comparison by End User: 2020 VS 2027
1.5.1. Biopharmaceutical Companies
1.5.2. Food & Beverage Companies
1.5.3. Academic & Research Institutes
1.5.4. Contract Research Organizations (CROs)
1.5.5. Forensic Science Laboratories
1.5.6. Diagnostic Centers
1.5.7. Others
1.6. Global Life Science Products Market Size Estimates and Forecasts by Region: 2020 VS 2027
1.6.1. North America Life Science Products Market Estimates
1.6.2. Europe Life Science Products Market Estimates
1.6.3. China Life Science Products Market Estimates
1.6.4. Japan Life Science Products Market Estimates
2. Market Competition by Manufacturers
2.1. Global Life Science Products Market Revenue Market Share by Manufacturers (2020)
2.2. Life Science Products Market Share by Company Product (Tier 1, Tier 2 and Tier 3)
2.3. Global Life Science Products Market Average Price by Manufacturers (2016-2021)
2.4. Manufacturers Life Science Products Market Production Sites, Area Served, Products
2.5. Life Science Products Market Competitive Situation and Trends
2.5.1. Life Science Products Market Concentration Rate
2.5.2. Mergers & Acquisitions, Expansion
3. Global Life Science Products Market Consumption by Region (2016-2021)
3.1. Global Life Science Products Market Consumption by Region
3.2. Global Life Science Products Market Consumption Market Share by Region
3.2.1. North America
3.2.2. North America Life Science Products Market Consumption Growth Rate (2016-2021)
3.2.3. North America Life Science Products Market Consumption, Price and Gross Margin (2016-2021)
3.2.4. North America Life Science Products Market Consumption by Country
3.2.4.1. U.S.
3.2.4.2. Canada
3.2.5. Europe
3.2.6. Europe Life Science Products Market Consumption Growth Rate (2016-2021)
3.2.7. Europe Life Science Products Market Consumption, Price and Gross Margin (2016-2021)
3.2.8. Europe Life Science Products Market Consumption by Country
3.2.8.1. Germany
3.2.8.2. U.K.
3.2.8.3. France
3.2.8.4. Italy
3.2.8.5. Spain
3.2.9. Asia Pacific
3.2.10. Asia Pacific Life Science Products Market Consumption Growth Rate (2016-2021)
3.2.11. Asia Pacific Life Science Products Market Consumption, Price and Gross Margin (2016-2021)
3.2.12. Asia Pacific Life Science Products Market Consumption by Country
3.2.12.1. China
3.2.12.2. India
3.2.12.3. Japan
3.2.12.4. Indonesia
3.2.12.5. Malaysia
3.2.12.6. Australia
3.2.12.7. South Korea
3.2.13. South America
3.2.14. South America Life Science Products Market Consumption Growth Rate (2016-2021)
3.2.15. South America Life Science Products Market Consumption, Price and Gross Margin (2016-2021)
3.2.16. South America Life Science Products Market Consumption by Country
3.2.16.1. Brazil
3.2.16.2. Mexico
3.2.16.3. Argentina
3.2.17. Middle East and Africa
3.2.18. Middle East and Africa Life Science Products Market Consumption Growth Rate (2016-2021)
3.2.19. Middle East and Africa Life Science Products Market Consumption, Price and Gross Margin (2016-2021)
3.2.20. Middle East and Africa Life Science Products Market Consumption by Country
3.2.20.1. Saudi Arabia
3.2.20.2. Kuwait
3.2.20.3. UAE
3.2.20.4. South Africa
4. Global Life Science Products Market Consumption by Product (2016-2021)
4.1. Global Life Science Products Market Price by Product (2016-2021)
4.2. Global Life Science Products Market Revenue Market Share by Product (2016-2021)
4.2.1. Recombinant Proteins
4.2.1.1. Immune Checkpoint Regulators
4.2.1.2. Chemokines
4.2.1.3. Growth Factors
4.2.1.4. Cytokines
4.2.1.5. Colony Stimulating Factors
4.2.1.6. Hormones
4.2.1.7. Enzymes & Inhibitors
4.2.1.8. Others
4.2.2. Cell Lines
4.2.2.1. Immunotherapy Cell Lines
4.2.2.2. Ion Channel Cell Lines
4.2.2.3. GPCR Cell Lines
4.2.2.4. Cell Signaling Pathway Cell Lines
4.2.2.5. Gene Knockout Cell Lines
4.2.2.6. Cancer Cell Lines
4.2.2.7. Others
4.2.3. Antibodies
4.2.3.1. Immune Checkpoint Antibodies
4.2.3.2. Epitope Tag Antibodies
4.2.3.3. Isotype Control Antibodies
4.2.3.3.1. Research Use
4.2.3.3.2. In-vivo Grade
4.2.3.4. Primary Antibodies
4.2.3.4.1. Research Use
4.2.3.4.2. In-vivo Grade
4.2.4. Assay Antibodies (includes secondary antibodies)
4.2.5. Others
4.2.5.1. Viable Tumor Samples
4.2.5.2. Tumor Tissue Microarrays
5. Global Life Science Products Market Consumption by Application (2016-2021)
5.1. Global Life Science Products Market Price by Application (2016-2021)
5.2. Global Life Science Products Market Revenue Market Share by Application (2016-2021)
5.2.1. Drug Discovery & Development
5.2.2. Tissue Engineering
5.2.3. Drug Screening
5.2.4. Toxicity Screening
5.2.5. Basic Research
5.2.6. Biopharmaceutical Production
5.2.7. Forensic Testing
6. Global Life Science Products Market Consumption by End User (2016-2021)
6.1. Global Life Science Products Market Price by End User (2016-2021)
6.2. Global Life Science Products Market Revenue Market Share by End User (2016-2021)
6.2.1. Food & Beverage Companies
6.2.2. Academic & Research Institutes
6.2.3. Contract Research Organizations (CROs)
6.2.4. Forensic Science Laboratories
6.2.5. Diagnostic Centers
6.2.6. Others
7. Key Companies Profiled
7.1. A.M.S. Biotechnology (Europe) Limited
7.1.1. A.M.S. Biotechnology (Europe) Limited Life Science Products Market Corporation Information
7.1.2. A.M.S. Biotechnology (Europe) Limited Life Science Products Market Product Portfolio
7.1.3. A.M.S. Biotechnology (Europe) Limited Life Science Products Market Consumption, Price and Gross Margin (2016-2021)
7.1.4. A.M.S. Biotechnology (Europe) Limited Main Business and Markets Served
7.1.5. A.M.S. Biotechnology (Europe) Limited Recent Developments/Updates
7.2. Agilent Technologies
7.3. Becton, Dickinson and Company
7.4. Bio-Rad Laboratories Inc.
7.5. BPS Bioscience Inc.
7.6. Bruker
7.7. Crown Bioscience Inc.
7.8. Danaher Corporation
7.9. F. Hoffmann-La Roche AG
7.10. Genscript Biotech Corporation
7.11. Hitachi, Ltd.
7.12. Illumina, Inc.
7.13. Merck KGaA
7.14. Oxford Instruments plc
7.15. PerkinElmer Inc.
7.16. QIAGEN
7.17. Shimadzu Corporation
7.18. Sigma Aldrich Corp.
7.19. Thermo Fisher Scientific Inc.
7.20. Zeiss International
8. Marketing Channel, Distributors and Customers
8.1. Marketing Channel
8.2. Life Science Products Market Distributors List
8.3. Life Science Products Market Customers
9. Market Dynamics
9.1. Life Science Products Market Industry Trends
9.2. Life Science Products Market Growth Drivers
9.3. Life Science Products Market Challenges
9.4. Life Science Products Market Restraints
10. Global Life Science Products Market Consumption and Demand Forecast, by Region (2022-2027)
10.1. Global Forecasted Demand Analysis of Life Science Products Market, by Regions and Country
10.1.1. North America Forecasted Consumption of Life Science Products Market by Country
10.1.2. Europe Market Forecasted Consumption of Life Science Products Market by Country
10.1.3. Asia Pacific Market Forecasted Consumption of Life Science Products Market by Region
10.1.4. Latin America Forecasted Consumption of Life Science Products Market by Country
10.1.5. Middle East and Africa Forecasted Consumption of Life Science Products Market by Country
11. Global Life Science Products Market Consumption and Demand Forecast, by Device Segments (2022-2027)
11.1. Global Forecasted Consumption of Life Science Products Market by Device Segments (2022-2027)
11.2. Global Consumption and Price Forecast by Device Segments (2022-2027)
11.3. Global Forecasted Growth Rate of Life Science Products Market by Device Segments (2022-2027)
12. Research Finding and Conclusion
13. Methodology and Data Source
13.1. Methodology/Research Approach
13.1.1. Research Programs/Product
13.1.2. Market Size Estimation
13.1.3. Market Breakdown and Data Triangulation
13.2. Data Source
13.2.1. Secondary Sources
13.2.2. Primary Sources
13.3. Author List
13.4. Disclaimer
Research Methodology
Our research studies are primarily performed in five phases which include Secondary Research, Primary Research, Subject Matter Expert Advice, Quality Check, and Final Review. The process opted for conducting thorough research to make authentic business reports is briefly described below-
Secondary Research-
- Based on the understanding of requirements, we conducted secondary research to identify the Segment specifications, qualitative and quantitative data along with the factors responsible for the growth of the market.
- The secondary sources referred for the study include press releases, company annual reports, and research papers related to the industry.
- Various sources such as industry magazines, trade journals, government websites, and associations were also reviewed for gathering precise analysis on opportunities for business expansions in the market.
- Moreover, quantitative as well as qualitative data were also extracted from paid databases, which included Reuters, Factiva, Bloomberg, One Source, and Hoovers, which proved to be useful for in-depth technical study of the market.
Primary Research-
- The research carried out during the desk research was verified by primary interviews. Primary research was scheduled with a number of industry experts for conducting telephonic interviews, and also our team send questionnaires through their official emails.
- The secondary data collected was then verified by various industry participants which included Segment managers, marketing managers, VPs, CEOs, purchasing managers, subject matter experts.
- An interview with the mentioned participants aids invalidation of our research findings regarding the Segment.
- It helps in the provision of first-hand data on factors such as market size, growth, regional trends, market trends, and competition in the industry. This approach makes our findings precise in order to help our clients in strategic decision-making processes.
Subject Matter Advice-
- The secondary and primary research key findings were then validated by the in-house subject matter experts having extensive experience in the market research industry.
- Specific requirements of the clients were reviewed by the experts to check for completion of the market study. Experts help in channelizing the representation skills of the analyst in terms of providing data that can be easily understood by our customers.
Quality Check-
- The analysis done by the research team was further reviewed to check for data accuracy provided to suit the clients’ specific requirements.
- This revision was done in various phases to check the data authenticity and to remove negligible errors in the final compilation.
Final Review-
- After the quality check, a final review of the report was done to look after the presentation, formatting, and to recheck if all the requirements of the clients were addressed. The next phase remains dispatch of the report to the client.
Enquire Before Purchase
Frequently Asked Questions
Why Choose Market Research Strategy?
We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports
We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround
Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.
We abide by the information security policy and adheres to keep your private and business information confidential and secure.